Investment Summary

Compass Capital Invests In Rameda

On January 1, 2011, private equity firm Compass Capital invested in life science company Rameda

Investment Highlights
  • This is Compass Capital’s 1st transaction in the Life Science sector.
  • This is Compass Capital’s 1st transaction in Egypt.

Investment Summary

Date 2011-01-01
Target Rameda
Sector Life Science
Investor(s) Compass Capital
Deal Type Stake Purchase

Target

Rameda

Giza, Egypt
Rameda is a pharmaceutical company with a broad portfolio of human and veterinary products. It has successfully built a scalable platform supported by three primary pillars people, product, and production. The company boasts an encouraging pipeline of new molecules in attractive therapeutic areas, has completed its second expansion drive which increased capacities by 40%, and is led by a capable and experienced management team that can deliver results. Rameda was founded in 1986 and is based in Giza, Egypt.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

DESCRIPTION

Compass Capital is a private equity firm focused on investments with potential for risk-adjusted returns. The Firm partners with management in a variety of industries, and invests in capital restructuring, growth capital, and operational turnaround situations. Compass Capital was founded in 2010 and is based in Giza, Egypt.


DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: Egypt M&A 1 of 2
Year: 2011 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-01 Bonyan

Cairo, Egypt

Bonyan is a specialty real estate developer operating in Egypt and the wider MENA region. In Egypt, Bonyan is building two state-of-the-art commercial real estate projects, namely design, furniture, and home accessories malls under its Designopolis brand. Bonyan is based in Cairo.

Buy -